Holdings
Tema Heart & Health ETF
As of May 31, 2026, Tema Heart & Health ETF reported 43 positions worth US$51.3M. Largest: Eli Lilly And Company, Unitedhealth Group Incorporated and Novo Nordisk A/s Class B. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 5,413 | US$5.98M | +150 | May 31, 2026 |
| Unitedhealth Group Incorporated | 7,159 | US$2.72M | −94 | May 31, 2026 |
| Novo Nordisk A/s Class B | 59,455 | US$2.72M | +27,866 | May 31, 2026 |
| Roche Holding Ltd | 5,436 | US$2.33M | −884 | May 31, 2026 |
| Merck & Company, Inc. | 18,672 | US$2.22M | −246 | May 31, 2026 |
| Astrazeneca Plc | 11,178 | US$2.08M | −1,528 | May 31, 2026 |
| Thermo Fisher Scientific Inc | 4,185 | US$2.06M | +48 | May 31, 2026 |
| Johnson & Johnson | 8,274 | US$1.86M | −2,536 | May 31, 2026 |
| Gilead Sciences, Inc. | 13,261 | US$1.78M | −174 | May 31, 2026 |
| Novartis Ag | 11,627 | US$1.76M | −154 | May 31, 2026 |